Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory G Schwartz

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Journal of the American College of Cardiology|April 17, 2024
Lipoprotein(a): An Equal Opportunity Risk FactorGregory G Schwartz
Journal of the American College of Cardiology|May 19, 2026
LDL Cholesterol: How Low to Go?Gregory G Schwartz
The American Journal of Cardiology|November 10, 2009
High-density lipoprotein cholesterol as a risk factor and target of therapy after acute coronary syndromeGregory G Schwartz
Journal of the American College of Cardiology|February 25, 2017
Who Should Receive Ezetimibe?Gregory G Schwartz
American Heart Journal|May 3, 2005
Statins in acute coronary syndromes: the sooner, the better?Gregory G Schwartz
Current Opinion in Lipidology|November 13, 2007
Lipid management after acute coronary syndromeGregory G Schwartz
Current Atherosclerosis Reports|November 16, 2011
New horizons for cholesterol ester transfer protein inhibitorsGregory G Schwartz
Current Atherosclerosis Reports|January 5, 2002
Lipid lowering in acute coronary syndromes: new evidence, new questionsGregory G Schwartz, Anders G Olsson
Journal of the American College of Cardiology|May 14, 2025
Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular ImplicationsGregory G Schwartz, Christa M Cobbaert
Annals of Medicine|May 17, 2002
Early initiation of treatment with statins in acute coronary syndromesAnders G Olsson, Gregory G Schwartz
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Journal of the American College of Cardiology|April 17, 2024
Lipoprotein(a): An Equal Opportunity Risk FactorGregory G Schwartz
Journal of the American College of Cardiology|May 19, 2026
LDL Cholesterol: How Low to Go?Gregory G Schwartz
The American Journal of Cardiology|November 10, 2009
High-density lipoprotein cholesterol as a risk factor and target of therapy after acute coronary syndromeGregory G Schwartz
Journal of the American College of Cardiology|February 25, 2017
Who Should Receive Ezetimibe?Gregory G Schwartz
American Heart Journal|May 3, 2005
Statins in acute coronary syndromes: the sooner, the better?Gregory G Schwartz
Current Opinion in Lipidology|November 13, 2007
Lipid management after acute coronary syndromeGregory G Schwartz
Current Atherosclerosis Reports|November 16, 2011
New horizons for cholesterol ester transfer protein inhibitorsGregory G Schwartz
Current Atherosclerosis Reports|January 5, 2002
Lipid lowering in acute coronary syndromes: new evidence, new questionsGregory G Schwartz, Anders G Olsson
Journal of the American College of Cardiology|May 14, 2025
Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular ImplicationsGregory G Schwartz, Christa M Cobbaert
Annals of Medicine|May 17, 2002
Early initiation of treatment with statins in acute coronary syndromesAnders G Olsson, Gregory G Schwartz
Pageof 19